Kiley Juergens Wealth Management, LLC Eli Lilly & CO Transaction History

Kiley Juergens Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$105.9 - $118.64 $178,865 - $200,382	-1,689 Closed	0 $0
Q3 2018 Oct 10, 2018	BUY	$85.86 - $107.31 $3,176 - $3,970	37 Added 2.24%	1,689 $181,000
Q2 2018 Jul 23, 2018	BUY	$75.7 - $86.88 $125,056 - $143,525	1,652 New	1,652 $140,000
Q1 2018 Apr 23, 2018	SELL	$74.21 - $87.6 $39,182 - $46,252	-528 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $43,264 - $46,405	528	528 $44,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Kiley Juergens Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kiley Juergens Wealth Management, LLC with notifications on news.